Summarising economic evaluations in systematic reviews: a new approach

BMJ. 2001 Jun 30;322(7302):1596-8. doi: 10.1136/bmj.322.7302.1596.
No abstract available

MeSH terms

  • Antineoplastic Agents, Hormonal / economics
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Cost-Benefit Analysis
  • Economics, Medical*
  • Economics, Pharmaceutical
  • Evidence-Based Medicine / methods*
  • Female
  • Humans
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / economics

Substances

  • Antineoplastic Agents, Hormonal